Literature DB >> 9103535

Nitric oxide-mediated inhibition of cytochrome P450 by interferon-gamma in human hepatocytes.

M T Donato1, M I Guillén, R Jover, J V Castell, M J Gómez-Lechón.   

Abstract

The role of nitric oxide in the inhibition of the cytochrome P450 system produced by interferon-gamma in human hepatocytes has been examined. Nitric oxide exogenously released from S-nitroso-N-acetylpenicillamine produced a dose-dependent decrease in cytochrome P4501A2 activity, assessed as 7-ethoxy resorufin O-deethylation. After 24 hr of treatment with 300 U/ml interferon-gamma, a rise in nitric oxide release (200% over control cells) and a parallel inhibition in 7-ethoxyresorufin O-deethylase activity (50% of control) were observed in human hepatocytes. This inhibition was concentration-dependently prevented by N(G)-monomethyl-L-arginine, a competitive inhibitor of nitric oxide biosynthesis. Comparable results were observed for cytochrome P4502A6 (7-coumarin hydroxylation), 2B6 (7-benzoxyresorufin O-dealkylation) and 3A4 (testosterone 6beta-hydroxylation) activities. Decreases in CYP1A2 activity found after exposure of 3-methylcholanthrene-treated hepatocytes to interferon-gamma were also reversed in the presence of N(G)-monomethyl-L-arginine. Down-regulation of cytochrome P4501A2 and 3A4 expression by interferon-gamma was observed in parallel. This study suggests that at least some of the interferon-gamma effects on human hepatocyte cytochrome P450 isoenzymes are mediated by nitric oxide biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9103535

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  16 in total

1.  Deletion of IFNγ enhances hepatocarcinogenesis in FXR knockout mice.

Authors:  Zhipeng Meng; Xiaoqiong Wang; Yichao Gan; Yunfeng Zhang; Hong Zhou; Carl Van Ness; Jun Wu; Guiyu Lou; Hua Yu; Chao He; Rongzhen Xu; Wendong Huang
Journal:  J Hepatol       Date:  2012-06-21       Impact factor: 25.083

Review 2.  Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies.

Authors:  Miroslav Dostalek; Iain Gardner; Brian M Gurbaxani; Rachel H Rose; Manoranjenni Chetty
Journal:  Clin Pharmacokinet       Date:  2013-02       Impact factor: 6.447

3.  Decreased antipyrine clearance following endotoxin administration: in vivo evidence of the role of nitric oxide.

Authors:  K Kitaichi; L Wang; K Takagi; M Iwase; E Shibata; M Nadai; T Hasegawa
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

4.  Regulation of cytochrome P450 enzyme activity and expression by nitric oxide in the context of inflammatory disease.

Authors:  Edward T Morgan; Cene Skubic; Choon-Myung Lee; Kaja Blagotinšek Cokan; Damjana Rozman
Journal:  Drug Metab Rev       Date:  2020-09-08       Impact factor: 4.518

5.  Significantly reduced cytochrome P450 3A4 expression and activity in liver from humans with diabetes mellitus.

Authors:  Miroslav Dostalek; Michael H Court; Bingfang Yan; Fatemeh Akhlaghi
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

6.  Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes.

Authors:  Alison E Aitken; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2007-06-18       Impact factor: 3.922

7.  Reaction of Mycobacterium tuberculosis cytochrome P450 enzymes with nitric oxide.

Authors:  Hugues Ouellet; Jérôme Lang; Manon Couture; Paul R Ortiz de Montellano
Journal:  Biochemistry       Date:  2009-02-10       Impact factor: 3.162

8.  Roles of nitric oxide in inflammatory downregulation of human cytochromes P450.

Authors:  Alison E Aitken; Choon-Myung Lee; Edward T Morgan
Journal:  Free Radic Biol Med       Date:  2007-12-23       Impact factor: 7.376

9.  TCDD-mediated suppression of the in vitro anti-sheep erythrocyte IgM antibody forming cell response is reversed by interferon-gamma.

Authors:  Colin M North; Byung-Sam Kim; Neil Snyder; Robert B Crawford; Michael P Holsapple; Norbert E Kaminski
Journal:  Toxicol Sci       Date:  2008-10-22       Impact factor: 4.849

10.  Regulation of hepatic cytochrome P450 expression in mice with intestinal or systemic infections of citrobacter rodentium.

Authors:  Madhusudana R Chaluvadi; Ryan D Kinloch; Beatrice A Nyagode; Terrilyn A Richardson; Malik J Raynor; Melanie Sherman; Leposava Antonovic; Henry W Strobel; Dirck L Dillehay; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2008-10-29       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.